Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Jit

Showing results (171-180 of 407) with videos related to

Pageof 41
Sort By:
BMC Medicine|August 13, 2021
SARS-CoV-2 infection risk during delivery of childhood vaccination campaigns: a modelling studySimon R Procter, Kaja Abbas, Stefan Flasche, et al.
Vaccine|January 26, 2010
Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluationMarc Baguelin, Albert Jan Van Hoek, Mark Jit, et al.
Vaccine|March 14, 2026
The potential global health impact and net monetary benefit of programmatic use of improved influenza vaccines: a mathematical modelling studyLucy Goodfellow, Adam Soble, Stefano Malvolti, et al.
Vaccine|April 29, 2015
Estimating costs of care for meningitis infections in low- and middle-income countriesAllison Portnoy, Mark Jit, Jeremy Lauer, et al.
Vaccine|June 27, 2020
The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two modelsRanju Baral, Xiao Li, Lander Willem, et al.
Vaccine|March 27, 2018
A bibliometric analysis of systematic reviews on vaccines and immunisationSilke Fernandes, Mark Jit, Fiammetta Bozzani, et al.
BMC Medicine|March 9, 2022
Differential health impact of intervention programs for time-varying disease risk: a measles vaccination modeling studyAllison Portnoy, Yuli Lily Hsieh, Kaja Abbas, et al.
Cost Effectiveness and Resource Allocation : C/E|May 15, 2023
What are economic costs and when should they be used in health economic studies?Hugo C Turner, Frank G Sandmann, Laura E Downey, et al.
The Lancet. Infectious Diseases|November 18, 2017
Use of mathematical modelling to assess the impact of vaccines on antibiotic resistanceKatherine E Atkins, Erin I Lafferty, Sarah R Deeny, et al.
The Lancet. Infectious Diseases|June 11, 2019
Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trialsAndrew Clark, Kevin van Zandvoort, Stefan Flasche, et al.
Pageof 41

Showing results (171-180 of 407) with videos related to

Sort By:
Pageof 41
BMC Medicine|August 13, 2021
SARS-CoV-2 infection risk during delivery of childhood vaccination campaigns: a modelling studySimon R Procter, Kaja Abbas, Stefan Flasche, et al.
Vaccine|January 26, 2010
Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluationMarc Baguelin, Albert Jan Van Hoek, Mark Jit, et al.
Vaccine|March 14, 2026
The potential global health impact and net monetary benefit of programmatic use of improved influenza vaccines: a mathematical modelling studyLucy Goodfellow, Adam Soble, Stefano Malvolti, et al.
Vaccine|April 29, 2015
Estimating costs of care for meningitis infections in low- and middle-income countriesAllison Portnoy, Mark Jit, Jeremy Lauer, et al.
Vaccine|June 27, 2020
The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two modelsRanju Baral, Xiao Li, Lander Willem, et al.
Vaccine|March 27, 2018
A bibliometric analysis of systematic reviews on vaccines and immunisationSilke Fernandes, Mark Jit, Fiammetta Bozzani, et al.
BMC Medicine|March 9, 2022
Differential health impact of intervention programs for time-varying disease risk: a measles vaccination modeling studyAllison Portnoy, Yuli Lily Hsieh, Kaja Abbas, et al.
Cost Effectiveness and Resource Allocation : C/E|May 15, 2023
What are economic costs and when should they be used in health economic studies?Hugo C Turner, Frank G Sandmann, Laura E Downey, et al.
The Lancet. Infectious Diseases|November 18, 2017
Use of mathematical modelling to assess the impact of vaccines on antibiotic resistanceKatherine E Atkins, Erin I Lafferty, Sarah R Deeny, et al.
The Lancet. Infectious Diseases|June 11, 2019
Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trialsAndrew Clark, Kevin van Zandvoort, Stefan Flasche, et al.
Pageof 41